Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Bradley Martin

Concepts (325)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Analgesics, Opioid
40
2024
553
8.950
Why?
Chronic Pain
17
2024
170
6.140
Why?
Opioid-Related Disorders
17
2024
386
4.290
Why?
Drug Overdose
10
2024
160
3.350
Why?
Medicaid
23
2021
254
2.880
Why?
Drug Prescriptions
14
2024
94
2.760
Why?
Tramadol
3
2024
30
2.510
Why?
Alcoholism
4
2022
232
2.490
Why?
Retrospective Studies
38
2024
6106
1.760
Why?
Antipsychotic Agents
9
2018
231
1.730
Why?
United States
49
2024
4870
1.660
Why?
Adult
55
2024
13325
1.660
Why?
Osteoarthritis, Knee
3
2017
88
1.570
Why?
Middle Aged
53
2024
12258
1.540
Why?
Pain
10
2018
374
1.480
Why?
Humans
95
2024
49863
1.450
Why?
Health Care Costs
9
2016
168
1.380
Why?
Medication Adherence
7
2016
131
1.330
Why?
Viscosupplements
3
2017
14
1.290
Why?
Anticoagulants
5
2023
253
1.290
Why?
Adolescent
36
2024
6392
1.290
Why?
Hyaluronic Acid
3
2017
35
1.270
Why?
Female
65
2024
26520
1.230
Why?
Male
62
2024
25439
1.190
Why?
Emergency Service, Hospital
6
2016
487
1.180
Why?
Young Adult
26
2024
4013
1.180
Why?
Schizophrenia
5
2009
257
1.140
Why?
Aged
37
2024
9434
1.130
Why?
Arthroplasty, Replacement, Knee
4
2017
279
1.090
Why?
Analgesics, Non-Narcotic
3
2012
115
1.080
Why?
Substance-Related Disorders
5
2021
592
1.060
Why?
Acetaminophen
4
2015
275
1.060
Why?
Patient Compliance
6
2009
230
1.020
Why?
Veterans
10
2024
564
0.990
Why?
Atrial Fibrillation
3
2016
182
0.970
Why?
Cohort Studies
14
2024
1400
0.970
Why?
Cross-Over Studies
1
2024
219
0.910
Why?
Asthma
3
2015
282
0.890
Why?
Prescription Drugs
6
2014
38
0.880
Why?
Cost-Benefit Analysis
5
2020
269
0.870
Why?
Insurance, Health
7
2020
131
0.840
Why?
Venous Thromboembolism
1
2023
67
0.810
Why?
Attention Deficit Disorder with Hyperactivity
1
2023
173
0.790
Why?
Neck Pain
2
2021
10
0.790
Why?
Back Pain
2
2021
38
0.780
Why?
Arkansas
14
2024
1982
0.770
Why?
Drug Utilization
11
2017
76
0.770
Why?
Central Nervous System Stimulants
1
2023
207
0.760
Why?
Hospitalization
6
2016
663
0.760
Why?
Arthralgia
1
2021
43
0.750
Why?
Professional-Patient Relations
1
2021
47
0.740
Why?
Insurance, Pharmaceutical Services
2
2019
25
0.730
Why?
Narcotic Antagonists
2
2024
135
0.700
Why?
Logistic Models
8
2016
895
0.700
Why?
Naloxone
1
2020
79
0.670
Why?
Hydrocodone
3
2024
20
0.650
Why?
Oxycodone
3
2024
26
0.650
Why?
Warfarin
3
2016
83
0.650
Why?
Legislation, Drug
1
2019
16
0.640
Why?
Contraception
1
2019
28
0.630
Why?
Decision Support Techniques
2
2016
71
0.630
Why?
Proton Pump Inhibitors
2
2016
85
0.630
Why?
Adrenal Cortex Hormones
2
2017
100
0.610
Why?
Follow-Up Studies
8
2024
2174
0.590
Why?
Mammography
1
2018
98
0.580
Why?
Buprenorphine
3
2024
143
0.580
Why?
Guidelines as Topic
1
2018
110
0.580
Why?
Practice Guidelines as Topic
3
2017
454
0.580
Why?
Histamine H2 Antagonists
1
2016
26
0.560
Why?
Peptic Ulcer
1
2016
14
0.560
Why?
Mental Disorders
6
2018
398
0.550
Why?
Purinergic P2Y Receptor Antagonists
3
2022
29
0.530
Why?
Education, Pharmacy, Graduate
1
2016
19
0.530
Why?
Pyridones
1
2016
35
0.520
Why?
Inappropriate Prescribing
1
2016
18
0.520
Why?
Risk
4
2020
313
0.520
Why?
Safety-Based Drug Withdrawals
1
2015
7
0.510
Why?
Dextropropoxyphene
1
2015
6
0.510
Why?
Health Expenditures
3
2011
67
0.510
Why?
For-Profit Insurance Plans
1
2015
2
0.510
Why?
Brain Ischemia
2
2016
157
0.500
Why?
Risk Factors
11
2024
3597
0.500
Why?
Pyrazoles
1
2016
114
0.490
Why?
Mass Screening
1
2018
346
0.490
Why?
Quinolines
1
2015
41
0.480
Why?
Stress, Psychological
1
2016
258
0.480
Why?
Acetates
1
2015
49
0.480
Why?
Time Factors
9
2018
2889
0.480
Why?
Anticonvulsants
2
2006
121
0.480
Why?
Diabetic Neuropathies
1
2015
49
0.480
Why?
Opiate Substitution Treatment
3
2024
93
0.480
Why?
Insurance Claim Reporting
2
2011
11
0.470
Why?
Critical Illness
1
2016
295
0.460
Why?
Insurance Claim Review
4
2010
36
0.460
Why?
Curriculum
2
2018
397
0.460
Why?
Pain Management
1
2015
164
0.450
Why?
Palliative Care
1
2016
185
0.450
Why?
Stroke
2
2016
479
0.440
Why?
Neoplasms
1
2023
1233
0.430
Why?
Breast Neoplasms
2
2023
1181
0.430
Why?
Databases, Factual
8
2022
660
0.430
Why?
Injections, Intra-Articular
3
2017
33
0.430
Why?
Computers, Handheld
1
2013
25
0.430
Why?
Prescription Drug Misuse
3
2024
33
0.430
Why?
United States Department of Veterans Affairs
5
2024
287
0.410
Why?
Age Factors
6
2018
1091
0.410
Why?
Benzodiazepines
3
2024
71
0.400
Why?
Cross-Sectional Studies
6
2022
1568
0.400
Why?
Health Personnel
2
2016
252
0.370
Why?
Community Pharmacy Services
3
2020
67
0.360
Why?
Kidney Failure, Chronic
2
2022
198
0.340
Why?
Case-Control Studies
6
2023
1129
0.330
Why?
Motor Vehicles
1
2009
15
0.320
Why?
Antidepressive Agents
2
2009
176
0.320
Why?
Automobile Driving
1
2009
22
0.320
Why?
Medication Errors
1
2009
26
0.320
Why?
Pharmacists
3
2019
143
0.310
Why?
Cost of Illness
3
2013
113
0.310
Why?
Quality-Adjusted Life Years
2
2020
63
0.300
Why?
Physicians, Primary Care
2
2018
46
0.300
Why?
Pain Measurement
6
2021
246
0.300
Why?
Health Resources
2
2012
74
0.300
Why?
College Admission Test
2
2018
13
0.290
Why?
Antimanic Agents
1
2007
14
0.290
Why?
School Admission Criteria
2
2018
35
0.280
Why?
Hypoglycemic Agents
1
2008
169
0.280
Why?
Schools, Pharmacy
2
2018
52
0.280
Why?
Orthopedic Procedures
2
2017
67
0.280
Why?
Propensity Score
2
2017
123
0.280
Why?
Pharmaceutical Services
2
2018
52
0.280
Why?
Constipation
1
2006
33
0.280
Why?
Overweight
1
2009
215
0.270
Why?
Least-Squares Analysis
4
2011
42
0.270
Why?
Medicare
4
2023
245
0.260
Why?
Georgia
5
2006
42
0.260
Why?
Platelet Aggregation Inhibitors
2
2021
174
0.260
Why?
Knee Joint
2
2017
161
0.260
Why?
Students, Pharmacy
2
2018
122
0.250
Why?
Odds Ratio
4
2020
547
0.250
Why?
Multivariate Analysis
3
2017
577
0.250
Why?
Controlled Substances
1
2024
6
0.240
Why?
Child
9
2019
6838
0.240
Why?
Risperidone
2
2010
25
0.240
Why?
North Carolina
5
2011
53
0.240
Why?
Polypharmacy
1
2004
14
0.240
Why?
Aged, 80 and over
8
2023
3132
0.240
Why?
Drug Costs
2
2020
39
0.230
Why?
Renal Dialysis
2
2022
170
0.220
Why?
Haloperidol
1
2003
47
0.220
Why?
Hemorrhage
2
2023
194
0.220
Why?
Direct Service Costs
1
2003
5
0.220
Why?
Irritable Bowel Syndrome
1
2003
17
0.210
Why?
Employment
1
2003
87
0.210
Why?
Prevalence
4
2018
951
0.210
Why?
Aftercare
1
2023
74
0.210
Why?
Dose-Response Relationship, Drug
5
2014
1354
0.210
Why?
Premedication
1
2002
18
0.210
Why?
Diabetes Mellitus, Type 2
1
2008
480
0.210
Why?
Age Distribution
4
2018
169
0.210
Why?
Health Services Needs and Demand
1
2004
154
0.200
Why?
Neuralgia
1
2023
63
0.200
Why?
Common Cold
1
2002
5
0.200
Why?
Bronchitis
1
2002
11
0.200
Why?
Proportional Hazards Models
4
2017
404
0.200
Why?
Thromboembolism
1
2002
54
0.200
Why?
Accidents
1
2021
21
0.200
Why?
Carcinoma, Non-Small-Cell Lung
1
2023
153
0.190
Why?
Depressive Disorder, Major
2
2020
150
0.190
Why?
Mental Health Services
1
2004
195
0.190
Why?
Forecasting
3
2009
145
0.190
Why?
Ambulatory Care Facilities
1
2002
121
0.190
Why?
Respiratory Tract Infections
1
2002
76
0.190
Why?
Interprofessional Relations
2
2018
85
0.180
Why?
Patient Discharge
1
2023
317
0.180
Why?
Afghan Campaign 2001-
2
2018
40
0.180
Why?
Administration, Oral
2
2016
432
0.180
Why?
Obesity
1
2009
1101
0.180
Why?
United States Food and Drug Administration
3
2011
91
0.180
Why?
Administration, Intranasal
1
2020
29
0.170
Why?
Cardiovascular Diseases
2
2018
443
0.170
Why?
Markov Chains
1
2020
30
0.170
Why?
Brain Neoplasms
1
2023
282
0.170
Why?
Social Media
1
2022
98
0.170
Why?
Preventive Health Services
1
2020
49
0.170
Why?
Child, Preschool
5
2011
3872
0.160
Why?
Regression Analysis
4
2013
385
0.160
Why?
Sepsis
1
2021
220
0.160
Why?
Insurance Coverage
1
2020
109
0.160
Why?
Drug Administration Schedule
3
2011
370
0.160
Why?
Delivery of Health Care
1
2021
308
0.160
Why?
Health Care Surveys
2
2011
174
0.160
Why?
Public Health Surveillance
1
2018
13
0.150
Why?
Thiazoles
2
2016
53
0.150
Why?
Sleep Deprivation
1
2018
16
0.150
Why?
Papillomavirus Vaccines
1
2019
67
0.150
Why?
Pharmacies
1
2019
60
0.150
Why?
Advisory Committees
1
2018
61
0.150
Why?
Physicians
1
2021
227
0.150
Why?
Chronic Disease
5
2011
563
0.150
Why?
Metabolic Diseases
1
2018
38
0.150
Why?
Lung Neoplasms
1
2023
600
0.150
Why?
Veterans Health
2
2014
62
0.140
Why?
Molecular Weight
1
2017
85
0.140
Why?
Acute Pain
1
2017
9
0.140
Why?
Papillomavirus Infections
1
2019
168
0.140
Why?
Treatment Outcome
7
2010
5165
0.140
Why?
Educational Measurement
1
2018
204
0.140
Why?
Monte Carlo Method
1
2016
86
0.140
Why?
Early Detection of Cancer
1
2018
163
0.130
Why?
Anti-Bacterial Agents
1
2002
743
0.130
Why?
Education, Pharmacy
1
2018
144
0.130
Why?
Health Services Accessibility
1
2020
414
0.130
Why?
Geriatrics
1
2016
44
0.130
Why?
Postoperative Complications
1
2002
1000
0.130
Why?
Sulfides
1
2015
28
0.120
Why?
Models, Theoretical
1
2016
172
0.120
Why?
Cyclopropanes
1
2015
23
0.120
Why?
Pyridines
1
2016
132
0.120
Why?
Renal Insufficiency, Chronic
1
2018
170
0.120
Why?
Thrombosis
1
2018
249
0.120
Why?
Anti-Asthmatic Agents
1
2015
29
0.120
Why?
Societies, Medical
1
2016
176
0.120
Why?
Severity of Illness Index
2
2016
953
0.120
Why?
Self Report
1
2016
202
0.120
Why?
Long-Term Care
3
2012
50
0.120
Why?
Health Literacy
1
2016
128
0.110
Why?
California
2
2004
87
0.110
Why?
Comorbidity
5
2017
607
0.110
Why?
Prescriptions
2
2011
10
0.110
Why?
Risk Assessment
2
2015
1253
0.110
Why?
Monitoring, Physiologic
1
2013
126
0.100
Why?
Sensitivity and Specificity
1
2015
855
0.100
Why?
Guideline Adherence
2
2023
133
0.100
Why?
Infant
3
2011
3565
0.100
Why?
Managed Care Programs
1
2012
36
0.100
Why?
Ticlopidine
1
2012
55
0.100
Why?
Deductibles and Coinsurance
1
2011
2
0.090
Why?
Hypertension, Pulmonary
1
2012
121
0.090
Why?
Body Mass Index
2
2013
654
0.090
Why?
Health Policy
1
2011
151
0.090
Why?
Calibration
1
2009
57
0.080
Why?
International Classification of Diseases
1
2009
63
0.080
Why?
Clozapine
2
2010
26
0.080
Why?
Reference Values
1
2009
302
0.080
Why?
Analysis of Variance
1
2010
553
0.080
Why?
Treatment Refusal
1
2009
35
0.080
Why?
Evidence-Based Medicine
1
2010
247
0.080
Why?
Carbamazepine
1
2007
13
0.070
Why?
Mental Health
1
2010
218
0.070
Why?
Lithium Compounds
1
2007
11
0.070
Why?
Alendronate
1
2007
23
0.070
Why?
Valproic Acid
1
2007
32
0.070
Why?
Fractures, Spontaneous
1
2007
14
0.070
Why?
Chemotherapy, Adjuvant
1
2007
121
0.070
Why?
Osteoporosis, Postmenopausal
1
2007
28
0.070
Why?
Affect
1
2007
97
0.070
Why?
Drug Labeling
1
2006
11
0.070
Why?
Bone Density Conservation Agents
1
2007
74
0.070
Why?
Predictive Value of Tests
1
2008
907
0.060
Why?
Adrenergic beta-Agonists
1
2005
41
0.060
Why?
Self Disclosure
1
2005
13
0.060
Why?
Drug Interactions
2
2018
208
0.060
Why?
Depression
1
2009
569
0.060
Why?
Eligibility Determination
1
2004
17
0.060
Why?
Factor Analysis, Statistical
1
2004
75
0.060
Why?
Urban Population
1
2005
151
0.060
Why?
Health Surveys
2
2018
234
0.060
Why?
Prescription Fees
1
2004
14
0.060
Why?
Length of Stay
1
2007
623
0.060
Why?
Algorithms
1
2007
613
0.060
Why?
Drug Therapy, Combination
1
2004
380
0.050
Why?
MEDLINE
1
2002
7
0.050
Why?
Prospective Studies
1
2008
2341
0.050
Why?
Enoxaparin
1
2002
27
0.050
Why?
Cognition Disorders
1
2003
199
0.050
Why?
Neuropsychological Tests
1
2003
345
0.050
Why?
Gastrointestinal Hemorrhage
1
2022
79
0.050
Why?
Longitudinal Studies
2
2014
693
0.050
Why?
Data Collection
1
2002
283
0.040
Why?
Patient Protection and Affordable Care Act
1
2020
51
0.040
Why?
Needs Assessment
1
2020
133
0.040
Why?
Quality of Health Care
1
2020
184
0.040
Why?
Incidence
2
2014
982
0.040
Why?
Pharmacoepidemiology
1
2017
8
0.040
Why?
Pharmacy
1
2018
54
0.040
Why?
Universities
1
2018
169
0.040
Why?
Vaccination
1
2019
275
0.040
Why?
Pilot Projects
1
2019
700
0.030
Why?
Communication
1
2018
246
0.030
Why?
Electronic Health Records
1
2018
209
0.030
Why?
Qualitative Research
1
2018
337
0.030
Why?
Reminder Systems
1
2016
27
0.030
Why?
Decision Making
1
2018
270
0.030
Why?
Medication Therapy Management
1
2016
24
0.030
Why?
Attitude of Health Personnel
1
2018
349
0.030
Why?
Ischemic Attack, Transient
1
2013
56
0.030
Why?
Lipids
1
2013
147
0.030
Why?
Survival Analysis
1
2014
669
0.030
Why?
Linear Models
1
2013
274
0.030
Why?
Stress Disorders, Post-Traumatic
1
2017
373
0.030
Why?
Diagnosis, Dual (Psychiatry)
1
2012
41
0.030
Why?
Diagnostic Tests, Routine
1
2012
28
0.020
Why?
Cost Control
1
2011
13
0.020
Why?
Acute Coronary Syndrome
1
2012
78
0.020
Why?
Blood Pressure
1
2013
517
0.020
Why?
Blood Glucose
1
2013
433
0.020
Why?
Dibenzothiazepines
1
2010
10
0.020
Why?
Adolescent Behavior
1
2011
103
0.020
Why?
Hypnotics and Sedatives
1
2010
76
0.020
Why?
Off-Label Use
1
2010
25
0.020
Why?
Diabetes Mellitus
1
2013
281
0.020
Why?
Mood Disorders
1
2009
58
0.020
Why?
Quinolones
1
2010
42
0.020
Why?
Anxiety Disorders
1
2009
126
0.020
Why?
Piperazines
1
2010
118
0.020
Why?
Headache
1
2008
75
0.020
Why?
Sex Factors
1
2009
690
0.020
Why?
Confidence Intervals
1
2007
155
0.020
Why?
Probability
1
2007
162
0.020
Why?
Drug Utilization Review
1
2005
23
0.020
Why?
Drug Monitoring
1
2005
78
0.020
Why?
Bone Density
1
2007
383
0.010
Why?
Registries
1
2007
522
0.010
Why?
Quality of Life
1
2008
837
0.010
Why?
Reproducibility of Results
1
2005
1180
0.010
Why?
Martin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description